Physician profile
Daniel J Katz
NPI 1881917060
$189,633.03
in general payments reported to CMS, 2019-2025
10 companies · $69K in 2025
The $69K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,737 · 2020: $5,651 · 2021: $2,500 · 2022: $25K · 2023: $27K · 2024: $59K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $96K · Consulting Fee: $48K · Honoraria: $7,920 · Travel and Lodging: $2,227 · Food and Beverage: $1,292 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $95,749.05 |
| Consulting Fee | $47,995.50 |
| Honoraria | $7,920.00 |
| Travel and Lodging | $2,227.00 |
| Food and Beverage | $1,292.21 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $103,446.04 | 2021-2025 | Fibryga |
| Stryker Corporation | $63,509.17 | 2022-2025 | Triton Canister System, Surgicount, Neptune |
| Csl Behring | $10,627.81 | 2023-2025 | Riastap |
| Instrumentation Laboratory Company | $5,920.00 | 2020-2024 | |
| Pacira Pharmaceuticals Incorporated | $4,163.56 | 2020-2023 | Exparel |
| Cerus Corporation | $1,537.05 | 2019 | |
| Werfen USA LLC | $409.59 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $19.81 | 2023 | Bridion |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.